Investors Capital Advisory Services’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-1,275
| Closed | -$61K | – | 708 |
|
|
2015
Q4 | $61K | Sell |
1,275
-910
| -42% | -$43.5K | 0.01% | 670 |
|
|
2015
Q3 | $79K | Sell |
2,185
-175
| -7% | -$6.33K | 0.02% | 663 |
|
|
2015
Q2 | $88K | Buy |
2,360
+530
| +29% | +$19.8K | 0.02% | 684 |
|
|
2015
Q1 | $72K | Buy |
1,830
+50
| +3% | +$1.97K | 0.01% | 690 |
|
|
2014
Q4 | $73K | Sell |
1,780
-395
| -18% | -$16.2K | 0.01% | 666 |
|
|
2014
Q3 | $96K | Sell |
2,175
-240
| -10% | -$10.6K | 0.02% | 639 |
|
|
2014
Q2 | $104K | Buy |
2,415
+260
| +12% | +$11.2K | 0.02% | 642 |
|
|
2014
Q1 | $88K | Sell |
2,155
-1,265
| -37% | -$51.7K | 0.02% | 615 |
|
|
2013
Q4 | $135K | Buy |
3,420
+515
| +18% | +$20.3K | 0.03% | 554 |
|
|
2013
Q3 | $119K | Buy |
2,905
+90
| +3% | +$3.69K | 0.03% | 526 |
|
|
2013
Q2 | $108K | Buy |
+2,815
| New | +$108K | 0.03% | 481 |
|